Cancer susceptibility in ataxia-telangiectasia

Leukemia

Volumn 6, Issue SUPPL. 1, 1992, Pages 8-13

  Peterson, Raymond D A ^a   Funkhouser, Jane D ^a   Tuck Muller, Cathy M ^a   Gatti, Richard A ^b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA; BLOOD; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CHILD; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME BREAKAGE; CONFERENCE PAPER; GENE REARRANGEMENT; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; LYMPHATIC SYSTEM TUMOR; LYMPHOCYTE CLONE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

ATAXIA TELANGIECTASIA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMAN; LEUKEMIA; MUTATION; NEOPLASMS;

EID: 0026528685     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Syllaba L, Henner K. Contribution a l'independance de l'athetose double idiopathique et congenitale. Rev Neurol 1926;1:541-562.
2. Louis-Bar D. Sur un syndrome progressif comprenent des telangiectasies capillaires cutanees et conjunctivales symetriques, a disposition naevoide et de troubles carebelleux. Conf Neurol (Basel) 1941;4:32-42.
3. Boder E, Sedgwick RP. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 1958;21:526-554.
4. Boder, E. Ataxia-telangiectasia: an overview. In: Gatti RA, Swift M, eds. Ataxia-telangiectasia: genetics, neuropathology and immunology of a degeneration disease of childhood. New York: Liss, 1985,pp.1-61.
5. Peterson RDA, Kelly W, Good RA. Ataxia-telangiectasia: its association with a defective thymus, immunological-deficiency disease and malignancy. Lancet 1964;i:1189-1193.
6. Peterson RDA, Cooper MD, Good RA. Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med 1966;41:342-359.
7. Waldmann TA, Misiti J, Nelson DL, Kraemer KH. Ataxia-telangiectasia: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, X-ray hypersensitivity, and a high incidence of neoplasia. Ann Intern Med 1983;99:367-379.
8. Swift M. Genetic aspects of ataxia-telangiectasia. Immunodeficiency Rev 1990;2:67-81.
9. Gatti RA, Berkel I, Boder E et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 1988;336:577-580.
10. McConville CM, Formstone CJ, Hernandez D, Thick J, Taylor AMR. Fine mapping of the chromosome 11q22-23 region using PFGE, linkage and haplotype analysis; localization of the gene for ataxia-telangiectasia to a 5 cM region flanked by NCAM/DRD2 and STMY/CJ52.75, theta 2.22. Nucleic Acid Res 1990;18:4335-4343.
11. Concannon P, Malhotra U, Charmley P, Reynolds J, Lange K, Gatti RA. The ataxia-telangiectasia gene (ATA) on chromosome 11 is distinct from the ETS-1 Gene. Am J Hum Genet 1990;46:789-794.
12. Sanal O, Wei S, Foroud T et al. Further mapping of an ataxia-telangiectasia locus to the chromosome 11q23 region. Am J Hum Genet 1990;47:860-866.
13. Wei S, Rocchi M, Archidiancono N, Sacchi N, Romeo G, Gatti RA. Physical mapping of the human chromosome 11q23 region containing the ataxia-telangiectasia locus. Cancer Gen Cytogenet 1990;46:1-8.
14. Ziv Y, Rotman G, Frydman M et al. The ATC ataxia-telangiectasia (complementation group C) locus localizes to 11q22-23. Genomics 1991;9:373-375.
15. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980;77:7315-7317.
16. Houldsworth J, Lavin MF. Effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nucleic Acid Res 1980;8:3709-3720.
17. Bates PR, Lavin MF. Comparison of gamma-radiation-induced accumulation of ataxia-telangiectasia and control cells in G2 phase. Mutation Res 1989;218:165-170.
18. Jaspers NGJ, Gatti RA, Baan C, Linssen PC, Bootsma D. Genetic complementation analysis of ataxia-telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet 1988;49:259-263.
19. Aurias A, Dutrillaux B. Probable involvement of immunoglobulin superfamily genes in most recurrent chromosomal rearrangements from ataxia-telangiectasia. Hum Genet 1986;72:210-214.
20. Stern MH, Zhang FR, Griscelli C, Thomas G, Aurias A. Molecular characterization of different ataxia-telangiectasia T-cell clones. I. A common breakpoint at the 14q11.2 band splits the T-cell receptor alpha-chain gene. Hum Gen 1988;78:33-36.
21. Gatti RA, Aurias A, Griscelli C, Sparkes RS. Translocations involving chromosomes 2p and 22q in ataxia-telangiectasia. Disease Markers 1985;3:169-175.
22. Stern M-H, Zhang F, Thomas G, Griscelli C, Aurias A. Molecular characterization of ataxia-telangiectasia T-cell clones. III. Mapping the 14q32.1 distal breakpoint. Hum Genet 1988;81:18-22.
23. Stern M-H, Theodorou I, Aurias A et al. T-cell nonmalignant clonal proliferation in ataxia-telangiectasia: A cytological, immunological, and molecular characterization. Blood 1989;73:1285-1290.
24. Stern M-H, Lipkowitz S, Aurias A, Griscelli C, Thomas G, Kirsch IR. Inversion of chromosome 7 in ataxia-telangiectasia is generated by a rearrangement between T-cell receptor beta and T-cell receptor gamma genes. Blood 1989;74:2076-2080.
25. Harrelson AL, Goodman CS. Growth cone guidance in insects: fasciclin II is a member of the immunoglobulin superfamily. Science 1988;242:700-708.
26. Williams AF. A year in the life of the immunoglobulin superfamily. Immunol Today 1987;8:298-303.
27. Breakefield XO, Hansen CR, Jr. Do DNA rearrangements occur in neuronal development? Clues from an inherited human disease. Trends Neurosci 1983;6:444-446.
28. Peterson RDA, Funkhouser JD. Speculations on ataxia-telangiectasia: defective regulation of the immunoglobulin gene superfamily. Immunol Today 1989;10:313-315.
29. Frizzera G, Rosai J, Dehner LP, Spector BD, Kersey JH. Lymphoreticular disorders in primary immunodeficiencies: New findings based on an up-to-date histologic classification of 35 cases. Cancer 1980;46:692-699.
30. Spector, BD, Filipovich, AH, Perry, GS III and Kersey, JH. Epidemiology of cancer in ataxia-telangiectasia. In: Bridges BA, Harnden DG, eds. Ataxia-telangiectasia. A cellular and molecular link between cancer, neuropathology, and immune deficiency. John Wiley, 1982, pp. 103-137.
31. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 1986;77:89-92.
32. Hecht F, Hecht BK. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenenet 1990;46:9-19.
33. Young JL, Miller RW. Incidence of malignant tumours in US children. J Pediatr 1975;86:254-258.
34. Swift M, Shoman L, Perry M, Chase C. Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res 1976;36:209-215.
35. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in ataxia-telangiectasia families. N Engl J Med 1987;316:1289-1294.
36. Swift M, Chase CL, Morrell D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 1990;46:21-27.
37. Pippard EC, Hall AJ, Barker DJ, Bridges BA. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988;48:2929-2932.
38. Hecht F, Koler RD, Rigas DA, Dahnke GS, Case MP, Tisdale V. Leukaemia and lymphocytes in ataxia-telangiectasia. Lancet 1966;ii:1193.
39. Taylor, AMR. Cytogenetics of ataxia-telangiectasia. In: Bridges BA, Harnden DG, eds. Ataxia-telangiectasia. A cellular and molecular link between cancer, neuropathology and immune deficiency. J. Wiley, 1982,pp.53-81.
40. Zhang F, Stern M-H, Thomas G, Aurias A. Molecular characterization of ataxia-telangiectasia T cell clones II. The clonal inv(14) in ataxia-telangiectasia differs from the inv(14) in T cell lymphoma. Hum Genet 1988; 78:316-319.
41. Lipkowitz S, Stern M-H, Kirsch IR. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J Exp Med 1990;172:409-418.
42. Kojis TL, Schreck RR, Gatti RA, Sparkes RS. Tissue specificity of chromosomal rearrangements in ataxia-telangiectasia. Hum Genet 1989;83:347-352.
43. Fiorilli M, Carbonari M, Crescenzi M, Russo G, Aiuti F. T-cell receptor genes and ataxia-telangiectasia. Nature 1985;313:186.
44. Hecht F, McCaw BK, Peakman D, Robinson A. Nonrandom occurrence of 7-14 translocations in human lymphocyte cultures. Nature 1975;225:241-244.
45. Davey MP, Bertness V, Nakahara K et al. Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. Proc Natl Acad Sci USA 1988;85:9287-9291.
46. Becker Y. Cancer in ataxia-telangiectasia patients: analysis of factors leading to radiation-induced and spontaneous tumors. Anticancer Res 1986;6:1021-1032.
47. Shaham M, Becker Y, Cohen MM. A diffusable clastogenic factor in ataxia-telangiectasia. Cytogenet Cell Genet 1980;27:155-161.
48. Shaham M, Becker Y. The ataxia-telangiectasia factor is a low molecular weight peptide. Hum Genet 1981;58:422-424.
49. Shaham M, Chorev M, Becker Y. Further characterization of the ataxia-telangiectasia clastogenic factor by reversed phase liquid chromatography. J Biotechnol 1984;1:351-354.
50. Sanford KK, Parshad R, Price FM et al. Enhanced chromatid damage in blood lymphocytes after G2 phase X irradiation, a marker of the ataxia-telangiectasia gene. J Natl Cancer Inst 1990;82:1050-1054.
51. Rosin MP, Ochs HD, Gatti RA, Boder E. Heterogeneity of chromosomal breakage levels in epithelial tissue of ataxia-telangiectasia homozygotes and heterozygotes. Hum Genet 1989;83:133-138.
52. Pawlak A, Kotecki M, Ignatowicz R. Increased frequency of chromatid breaks in lymphocytes of heterozygotes of ataxia-telangiectasia after in vitro treatment with caffeine. Mutation Res 1990;230:197-204.
53. Humphreys MW, Nevin NC, Wooldridge MAW. Cytogenetic investigations in a family with ataxia-telangiectasia. Hum Genet 1989;83:79-82.
54. Shiloh Y, Parshad R, Frydman M et al. G2 chromosomal radiosensitivity in families with ataxia-telangiectasia. Hum Genet 1989:84:15-18.
55. Waghray M, Al-Sedairy S, Ozand PT, Hannan MA. Cytogenetic characterization of ataxia-telangiectasia (AT) heterozygotes using lymphoblastoid cell lines and chronic gamma-irradiation. Hum Genet 1990; 84:532-534.
56. Painter RB. Radioresistant DNA synthesis: an intrinsic feature of ataxia-telangiectasia. Mutation Res 1981;84:183-190.
57. Russo G, Isobe M, Pegoraro L, Finan J, Nowell PC, Croce CM. Molecular analysis of a t(7;14) (q35;q32) chromosome translocation in a T-cell leukemia of a patient with ataxia-telangiectasia. Cell 1988;53:137-144.
58. Russo G, Isobe M, Gatti RA et al. Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia-telangiectasia patient. Proc Natl Acad Sci USA 1989;86:602-606.
59. Johnson JP, Gatti RA, Sears TS, White RL. Inverted duplication of JH associated with chromosome 14 translocation and T-cell leukemia in ataxia-telangiectasia. Am J Hum Genet 1986;39:787-796.
60. Heppell A, Butterworth SV, Hollis RJ, Kennaugh AA, Beatty DW, Taylor AMR. Breakage of the T-cell receptor alpha chain locus in non-malignant clones from patients with ataxia-telangiectasia. Hum Genet 1988;79:360-364.
61. Schlegelberger B, Feller AC, Wacker H-H, Lohmeyer J, Grote W. Inv(14) with distal breakpoint in 14q32.1 in three case of T-cell lymphoma. Hum Genet 1990;85:80-84.
62. Hecht F, Kaiser-McCaw Hecht B. Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Am J Pediatr Hematol Oncol 1987;9:185-188.
63. Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D. Cytogenetic studies on prolymphocytic leukemia. II. T-cell prolymphocytic leukemia. Blood 1987;70:929-931.
64. Brown L Cheng J-T, Chen Q et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T-cell leukemia. Eur Mol Biol Org (EMBO) J 1990;9:3343-3351.
65. Yancopoulos GD, Blackwell TK, Suh H, Hood L, Alt FW. Introduced T-cell receptor variable region gene segments recombine in pre-B cells: Evidence that B- and T-cells use a common recombinase. Cell 1986;44:251-259.
66. McDonnell TJ, Korsmeyer SJ. Progression from Iymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349:254-256.
67. Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T-cell leukemia. Science 1991;253:79-82.